1.Cooperberg MR and Chan JM: Epidemiology of prostate cancer. World journal of urology
35: 849, 2017.
2.Lee DJ, Mallin K, Graves AJ, Chang SS, Penson DF, Resnick MJ and Barocas DA: Recent
Changes in Prostate Cancer Screening Practices and Epidemiology. The Journal of urology
198: 1230-1240, 2017.
3.Cooperberg MR, Lubeck DP, Mehta SS and Carroll PR: Time trends in clinical risk stratification
for prostate cancer: implications for outcomes (data from CaPSURE). The Journal of
urology 170: S21-25; discussion S26-27, 2003.
4.Walsh PC, DeWeese TL and Eisenberger MA: Clinical practice. Localized prostate cancer.
The New England journal of medicine 357: 2696-2705, 2007.
5.Budaus L, Huland H and Graefen M: Controversies in the management of localized prostate
cancer: radical prostatectomy still the standard of care. Critical reviews in oncology/hematology
84 Suppl 1: e24-29, 2012.
6.Fossati N, Wiklund P, Rochat CH, Montorsi F, Dasgupta P, Sanchez-Salas R, Canda AE,
Piechaud T, Artibani W and Mottrie A: Robotic and Open Radical Prostatectomy: The
First Prospective Randomised Controlled Trial Fuels Debate Rather than Closing the
Question. European urology 71: 307-308, 2017.
7.Norderhaug I, Dahl O, Hoisaeter PA, Heikkila R, Klepp O, Olsen DR, Kristiansen IS,
Waehre H and Bjerklund Johansen TE: Brachytherapy for prostate cancer: a systematic
review of clinical and cost effectiveness. European urology 44: 40-46, 2003.
8.Yamada Y, Rogers L, Demanes DJ, Morton G, Prestidge BR, Pouliot J, Cohen GN, Zaider
M, Ghilezan M and Hsu IC: American Brachytherapy Society consensus guidelines for
high-dose-rate prostate brachytherapy. Brachytherapy 11: 20-32, 2012.
9.Sharkey J, Cantor A, Solc Z, Huff W, Chovnick SD, Behar RJ, Perez R, Otheguy J and
Rabinowitz R: 103Pd brachytherapy versus radical prostatectomy in patients with clinically
localized prostate cancer: a 12-year experience from a single group practice. Brachytherapy
4: 34-44, 2005.
10.Liu L, Han R and Liu C: Comparison of the efficacy of brachytherapy and radical prostatectomy
in the treatment of localized prostate cancer - a meta-analysis. Journal of Modern
Urology 13: 288-290, 2008.
11.Weiss MA: Urologic Surgical Pathology/ Urologic surgical pathology. Mosby 188, 1997.
12.Bostwick DG, Myers RP and Oesterling JE: Staging of prostate cancer. Seminars in surgical
oncology 10: 60-72, 1994.
13.Sun M, Sammon JD, Becker A, Roghmann F, Tian Z, Kim SP, Larouche A, Abdollah F, Hu
JC, Karakiewicz PI, et al: Radical prostatectomy vs radiotherapy vs observation among older patients with clinically
localized prostate cancer: a comparative effectiveness evaluation. BJU international
113: 200-208, 2014.
14.Schostak M, Miller K and Schrader M: Radical prostatectomy in the 21st century - the
gold standard for localized and locally advanced prostate cancer. Frontiers of radiation
therapy and oncology 41: 7-14, 2008.
15.Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C, Nordling S, Haggman
M, Andersson SO, Bratell S, et al: Radical prostatectomy versus watchful waiting in localized prostate cancer: the
Scandinavian prostate cancer group-4 randomized trial. Journal of the National Cancer
Institute 100: 1144-1154, 2008.
16.Boehm K, Schiffmann J, Tian Z, Lesmana H, Larcher A, Mandel P, Karakiewicz PI, Graefen
M, Schwarz R, Krull A, et al: Five-year biochemical recurrence-free and overall survival following high-dose-rate
brachytherapy with additional external beam or radical prostatectomy in patients with
clinically localized prostate cancer. Urologic oncology 34: 119.e111-118, 2016.
17.Miralbell R, Roberts SA, Zubizarreta E and Hendry JH: Dose-fractionation sensitivity
of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international
institutional datasets: alpha/beta = 1.4 (0.9-2.2) Gy. International journal of radiation
oncology, biology, physics 82: e17-24, 2012.
18.Ritter M, Forman J, Kupelian P, Lawton C and Petereit D: Hypofractionation for prostate
cancer. Cancer journal (Sudbury, Mass) 15: 1-6, 2009.
19.Tselis N and Zamboglou N: High-Dose-Rate Brachytherapy in the Treatment of Clinically
Localized Prostate Cancer/ Radiotherapy in Prostate Cancer. Springer Berlin Heidelberg
211-224, 2014.
20.Ferrer M, Suarez JF, Guedea F, Fernandez P, Macias V, Marino A, Hervas A, Herruzo
I, Ortiz MJ, Villavicencio H, et al: Health-related quality of life 2 years after treatment with radical prostatectomy,
prostate brachytherapy, or external beam radiotherapy in patients with clinically
localized prostate cancer. International journal of radiation oncology, biology, physics
72: 421-432, 2008.
21.Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R and Kuban DA: An assessment of quality
of life following radical prostatectomy, high dose external beam radiation therapy
and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
The Journal of urology 177: 2151-2156; discussion 2156, 2007.